Preintubation Application of Oral Chlorhexidine Does Not Provide Additional Benefit in Prevention of Early-Onset Ventilator-Associated Pneumonia

BACKGROUND: Daily application of oral chlorhexidine gluconate (CHX) following intubation to reduce the risk of ventilator-associated pneumonia (VAP) is now the standard of care in many ICUs. This randomized clinical trial evaluated the benefit of adding a preintubation CHX dose to the known benefit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chest
Main Authors: Munro, Cindy L., Grap, Mary Jo, Sessler, Curtis N., Elswick, Ronald K., Mangar, Devanand, Karlnoski-Everall, Rachel, Cairns, Paula
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Chest Physicians 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314813/
https://ncbi.nlm.nih.gov/pubmed/25317722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.14-0692
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados